Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may spot schizophrenia early and guide treatment

NCT ID NCT07703670

Recruiting now Knowledge-focused Sponsor: Northwell Health Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study investigates whether microRNAs found in brain-derived particles in the blood can serve as biomarkers for schizophrenia. Researchers will compare blood samples from 80 people recently diagnosed with first-episode schizophrenia and 80 healthy volunteers, tracking changes over 12 weeks of treatment. The goal is to see if these molecules can help diagnose schizophrenia faster and predict which medication will work best for each person.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test to diagnose schizophrenia earlier and help doctors choose the right medication faster.
What could go wrong
This is an early-stage observational study. The microRNA patterns may not prove reliable enough for clinical use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOSIS NOT OTHERWISE SPECIFIED (NOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychotic disorder Psychotic Disorders schizoaffective disorder schizophrenia schizophreniform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSYCHOSIS NOT OTHERWISE SPECIFIED (NOS) SCHIZOAFFECTIVE DISORDER SCHIZOPHRENIA DISORDER SCHIZOPHRENIFORM DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zucker Hillside Hospital

    RECRUITING

    Glen Oaks, New York, 11004, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.